Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Hormone Receptor Positive Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Letrozole|DRUG: Exemestane|DRUG: Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study)|DRUG: Standard of care to treat stomatitis (Stomatitis sub-study)
Sponsor: Novartis Pharmaceuticals